Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression
Condition:   Advanced Solid Tumor
Interventions:   Drug: BT7480;   Drug: Nivolumab
Sponsor:   BicycleTx Limited
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 21, 2021Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments